CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Grant or award Director acquired 25,797 shares (grant or award)
- 4 Open-market buy CEO & President bought 20,000 shares at $0.21 ($4,240)
- 4 Grant or award Director acquired 27,412 shares (grant or award)
- 4 Grant or award Director acquired 27,412 shares (grant or award)
- 4 Grant or award Director acquired 8,768 shares (grant or award)
- 4 Grant or award Director acquired 26,305 shares (grant or award)
- 4 Grant or award Director acquired 26,305 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 4,580 shares at $0.19 ($884)
- 4 Open-market buy CEO & President bought 22,727 shares at $0.21 ($4,682)
- 4 Grant or award Director acquired 24,452 shares (grant or award)
- 4 Grant or award Director acquired 24,452 shares (grant or award)
- 4 Grant or award Director acquired 24,452 shares (grant or award)
- 4 Open-market buy Director bought 11,112 shares at $0.21 ($2,356)
- 4 Grant or award Director acquired 22,645 shares (grant or award)
- 4 Grant or award Director acquired 22,645 shares (grant or award)
- 4 Grant or award Director acquired 22,645 shares (grant or award)
- 4 Open-market buy CEO & President bought 85,000 shares at $0.20 ($16,915)
- 4 Open-market buy Director bought 81,953 shares at $0.19 ($15,817)
- 4 Open-market buy CEO & President bought 60,110 shares at $0.18 ($11,000)
Page 3 of 31 · 614 filings